Of note, an FDA-approved small-molecule compound, lanatoside C, was found to combine with ZDHHC21 and suppress DLBCL cell growth in vitro and in vivo by regulating ZDHHC21/FASN axis and fatty acid synthesis. The gene discussed is ZDHHC21; the disease is diffuse large B-cell lymphoma.